SELECT
» Drugs in development
» Biotechnology facts and figures
» Key Technologies
DISEASES
» Anemia (2005)
» Breast Cancer (2007)
» Cardiovascular Diseases (2007)
» Diabetes (2005)
» Growth Hormone Deficiency (2005)
» Haemophilia (2005)
» Hepatitis B (2005)
» Inflammatory Bowel Disease (2007)
» Lymphomas (2005)
» Multiple Sclerosis (2005)
» Rheumatoid Arthritis and other Inflammatory Rheumatism (2007)
Partnerships
<div><span style="font-weight: bold; font-size: 13px; font-family: Arial,Helvetica,sans-serif; color: rgb(0, 153, 255); text-align: left;">BIA</span></div> <div><span>The BIA exists to promote the human health benefits of new bioscience technologies, encouraging the commercial success of the bioscience industry by focusing on emerging enterprise and the related interests of companies with whom such enterprise trades. The BIA supports member interests by lobbying Government and Parliament in the UK and Brussels, providing high quality information and business services, and attracting investment from both private and Government sources. </span><a target="_blank" href="http://www.bioindustry.org/">www.bioindustry.org</a></div> <div> </div> <div><span style="font-weight: bold; font-size: 13px; font-family: Arial,Helvetica,sans-serif; color: rgb(0, 153, 255); text-align: left;">EUROPABIO</span></div> <div><span>EuropaBio, the European Association for Bioindustries, has 70 direct members operating Worldwide, 12 associate members and 5 bioregions as well as 24 national biotechnology associations representing some 1800 small and medium sized enterprises involved in research and development, testing, manufacturing and distribution of products. </span><a href="http://www.europabio.org/">www.europabio.org</a></div> <div> </div> <div><span style="font-weight: bold; font-size: 13px; font-family: Arial,Helvetica,sans-serif; color: rgb(0, 153, 255); text-align: left;">FRANCE BIOTECH</span></div> <div>France Biotech is the French biotechnology association and the industry representative. <span>Its mission is to contribute to position France and Europe as leaders in the Life sciences industry. </span>France Biotech gathers 150 members, representing most of the French biotechnology investments, pipeline and employees.</div> <div><a href="http://www.france-biotech.org/">www.france-biotech.org</a></div> <div> </div> <div><span style="font-weight: bold; font-size: 13px; font-family: Arial,Helvetica,sans-serif; color: rgb(0, 153, 255); text-align: left;">LEEM</span></div> <div><span>Leem is the french medicine companies association, and brings together companies operating in France which represent 98.7% of the French medicines market. Leem is committed to representing the companies which joined the association, facilitating meetings and exchanges between its member, elaborating the ethic code, and ensuring it is respected. </span>The Leem Biotechnology Committee was founded in March 2004 to gather French biotechnology actors involved in medicine companies.</div> <div><a target="_blank" href="http://www.leem.org/">www.leem.org</a></div> <div> </div> <div><span style="font-weight: bold; font-size: 13px; font-family: Arial,Helvetica,sans-serif; color: rgb(0, 153, 255); text-align: left;">LIR</span></div> <div><span>LIR is the international association of research laboratories whose activities are focused on research and development. LIR was founded to raise awareness and promote the role of innovation in the improvement of public health; to highlight the contributions of medicines from both an economical and therapeutic stand points; to make understand the need for a medicine politics that takes into account industrial, research, exportations and jobs factors while taking into account patients' interests and financial balance of Health Insurance.</span></div> <div><a href="http://www.lir.asso.fr/">www.lir.asso.fr</a></div> <p> </p>
